Loading...
•
Jun 30, 2021
Bio-Techne Q4 2021 Earnings Report
Bio-Techne team delivered strong organic growth and profitability.
Key Takeaways
Bio-Techne reported a strong fourth quarter with a 39% increase in organic revenue and an adjusted operating margin of 38.5%. The company's Protein Sciences and Diagnostics and Genomics segments achieved record organic growth. Management sees continued momentum as they penetrate the life science markets.
Fourth quarter organic revenue increased by 39% (47% reported) to $259.0 million.
GAAP EPS was $0.37 versus $1.48 one year ago. Adjusted EPS of $1.87 versus $1.00 one year ago.
Adjusted Operating Margin increased to 38.5% in the fourth quarter of fiscal 2021 compared to 31.1% in the fourth quarter of fiscal 2020.
Protein Sciences and Diagnostics and Genomics achieving record organic growth of 46% and 22%, respectively.
Revenue by Segment
Forward Guidance
Bio-Techne sees continued momentum as they increase their penetration into the life science markets they serve, and their businesses reach and exceed the tipping points in size necessary to accelerate growth.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...